Literature DB >> 18190784

Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists.

Dawon Kang1, Gyu-Tae Kim, Eun-Jin Kim, Jun-Ho La, Jeong-Soon Lee, Eun-Shin Lee, Jae-Yong Park, Seong-Geun Hong, Jaehee Han.   

Abstract

Dorsal root ganglion (DRG) neurons express mRNAs for numerous two-pore domain K(+) (K(2P)) channels and G-protein coupled receptors (GPCR). Recent studies have shown that TRESK is a major background K(+) channel in DRG neurons. Here, we demonstrate the pharmacological properties of TRESK, including GPCR agonist-induced effects on DRG neurons. TRESK mRNA was highly expressed in DRG compared to brain and spinal cord. Similar to cloned TRESK, native TRESK was inhibited by acid and arachidonic acid (AA), but not zinc. Native TRESK was also activated by GPCR agonists such as acetylcholine, glutamate, and histamine. The glutamate-activated TRESK was blocked by lamotrigine in DRG neurons. In COS-7 cells transfected with mouse TRESK, 30 microM lamotrigine inhibited TRESK by approximately 50%. Since TRESK is target of modulation by acid, AA, GPCR agonists, and lamotrigine, it is likely to play an active role in the regulation of excitability in DRG neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190784     DOI: 10.1016/j.bbrc.2008.01.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

Review 1.  Properties, regulation, pharmacology, and functions of the K₂p channel, TRESK.

Authors:  Péter Enyedi; Gábor Czirják
Journal:  Pflugers Arch       Date:  2014-11-05       Impact factor: 3.657

2.  Physiological basis of tingling paresthesia evoked by hydroxy-alpha-sanshool.

Authors:  Richard C Lennertz; Makoto Tsunozaki; Diana M Bautista; Cheryl L Stucky
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

3.  Nonmigraine-associated TRESK K+ channel variant C110R does not increase the excitability of trigeminal ganglion neurons.

Authors:  Zhaohua Guo; Ping Liu; Fei Ren; Yu-Qing Cao
Journal:  J Neurophysiol       Date:  2014-05-07       Impact factor: 2.714

4.  TRESK background K(+) channel is inhibited by phosphorylation via two distinct pathways.

Authors:  Gábor Czirják; Péter Enyedi
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  Functional analysis of a migraine-associated TRESK K+ channel mutation.

Authors:  Ping Liu; Zheman Xiao; Fei Ren; Zhaohua Guo; Ziwei Chen; Hucheng Zhao; Yu-Qing Cao
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

6.  Selective Small Molecule Activators of TREK-2 Channels Stimulate Dorsal Root Ganglion c-Fiber Nociceptor Two-Pore-Domain Potassium Channel Currents and Limit Calcium Influx.

Authors:  Prasanna K Dadi; Nicholas C Vierra; Emily Days; Matthew T Dickerson; Paige N Vinson; C David Weaver; David A Jacobson
Journal:  ACS Chem Neurosci       Date:  2016-11-23       Impact factor: 4.418

7.  Selective and state-dependent activation of TRESK (K2P 18.1) background potassium channel by cloxyquin.

Authors:  Miklós Lengyel; Alice Dobolyi; Gábor Czirják; Péter Enyedi
Journal:  Br J Pharmacol       Date:  2017-05-18       Impact factor: 8.739

8.  The LQLP calcineurin docking site is a major determinant of the calcium-dependent activation of human TRESK background K+ channel.

Authors:  Gábor Czirják; Péter Enyedi
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

9.  Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK regulation.

Authors:  Gábor Czirják; Drazsen Vuity; Péter Enyedi
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

10.  Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel.

Authors:  J Kyle Bruner; Beiyan Zou; Hongkang Zhang; Yixin Zhang; Katharina Schmidt; Min Li
Journal:  Eur J Pharmacol       Date:  2014-06-24       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.